A research group from the Universities of Granada and León has proved that mononuclear blood cells from human umbilical cord can be an effective alternative to bone marrow.
- This work, which will be published in the journal Cell Transplantation, means a great advance in regenerative hepatic medic…

“New” drug is already approved for lowering cholesterol

Researchers at the OU Health Sciences Center have found a new use for an old drug. Their findings appear online Friday in the American Journal of Gastroenterology.

The drug, Fluvastatin, has been approved since 1993 by the U.S. Food …

Genotype D is found to be the only detected type in different clinical forms of HBV infections, including cirrhosis, among residents of southwestern Iran. A significant association between the presence of anti-HBe antibody and increasing ALT levels among either HBeAg-negative or HBeAg-positive indiv…

MGH study reveals mechanism key to maintaining chronic infection, potential therapy target

A compound that naturally occurs in grapefruit and other citrus fruits may be able to block the secretion of hepatitis C virus (HCV) from infected cells, a process required to maintain chronic infection. A …

For patients with hepatitis C, having a low blood platelet count is a frequent complication associated with advanced disease. This problem is compounded by the fact that standard antiviral treatment for the disease can further reduce platelet numbers to dangerously low levels, effectively denying th…

The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs. In patients with compensated (early stage) hepatitis C virus-related cirrhosis, antiviral combined …

STANFORD, Calif. - One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.

Those infected with…

Hepatitis C Virus (HCV) infects up to 500,000 people in the UK alone, many of the infections going undiagnosed. It is the single biggest cause of people requiring a liver transplant in Britain. Now scientists have found monoclonal antibodies which may make a successful vaccine a reality, researchers…

By Will Boggs, MD

NEW YORK (Reuters Health) Aug 15 (updated Aug 23) - Early and rapid virological response of chronic hepatitis C virus (HCV) infection to treatment with interferon and ribavirin predicts sustained virological response in patients co-infected with HIV and HCV, according to finding…

Filed under: Non-Hodgkins Lymphoma, Liver Cancer, Daily newsIf living with Hepatitis C isn’t trying abundant, studies are showing that citizens living with the chronic condition are at a greater risk for developing Non-Hodgkin’s Lymphoma, based on research done on US soldiers living with Hep C. Hep …